New product marketing blurs the line between nicotine replacement therapy and smokeless tobacco products

G. Kostygina, L. England and P. Ling

American Journal of Public Health, 2016, vol. 106, issue 7, 1219-1222

Abstract: Tobacco companies have begun to acquire pharmaceutical subsidiaries and recently started to market nicotine replacement therapies, such as Zonnic nicotine gum, in convenience stores. Conversely, tobacco companies are producing tobacco products such as tobacco chewing gum and lozenges that resemble pharmaceutical nicotine replacement products, including a nicotine pouch product that resembles snus pouches. This convergence of nicotine and tobacco product marketing has implications for regulation and tobacco cessation.

Keywords: nicotine gum, advertising; economics; human; legislation and jurisprudence; marketing; organization and management; procedures; smokeless tobacco; smoking cessation, Advertising as Topic; Humans; Marketing; Smoking Cessation; Tobacco Use Cessation Products; Tobacco, Smokeless (search for similar items in EconPapers)
Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.2105/AJPH.2016.303057

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aph:ajpbhl:10.2105/ajph.2016.303057_8

DOI: 10.2105/AJPH.2016.303057

Access Statistics for this article

American Journal of Public Health is currently edited by Alfredo Morabia

More articles in American Journal of Public Health from American Public Health Association
Bibliographic data for series maintained by Christopher F Baum ().